R 74893
Latest Information Update: 28 Jul 1994
At a glance
- Originator Janssen L.P.
- Class Antiarrhythmics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias